Regent Peak Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $665K | Sell |
1,337
-35
| -3% | -$17.4K | 0.16% | 66 |
|
|
2024
Q4 | $714K | Sell |
1,372
-11
| -0.8% | -$5.72K | 0.16% | 66 |
|
|
2024
Q3 | $855K | Sell |
1,383
-43
| -3% | -$26.6K | 0.2% | 67 |
|
|
2024
Q2 | $788K | Buy |
1,426
+23
| +2% | +$12.7K | 0.18% | 71 |
|
|
2024
Q1 | $815K | Buy |
1,403
+49
| +4% | +$28.5K | 0.21% | 67 |
|
|
2023
Q4 | $719K | Sell |
1,354
-99
| -7% | -$52.5K | 0.2% | 67 |
|
|
2023
Q3 | $735K | Buy |
1,453
+15
| +1% | +$7.59K | 0.22% | 66 |
|
|
2023
Q2 | $750K | Sell |
1,438
-1
| -0.1% | -$522 | 0.22% | 66 |
|
|
2023
Q1 | $829K | Sell |
1,439
-72
| -5% | -$41.5K | 0.26% | 57 |
|
|
2022
Q4 | $833K | Sell |
1,511
-7
| -0.5% | -$3.86K | 0.27% | 62 |
|
|
2022
Q3 | $770K | Buy |
1,518
+24
| +2% | +$12.2K | 0.27% | 66 |
|
|
2022
Q2 | $811K | Buy |
1,494
+26
| +2% | +$14.1K | 0.27% | 61 |
|
|
2022
Q1 | $867K | Sell |
1,468
-45
| -3% | -$26.6K | 0.25% | 58 |
|
|
2021
Q4 | $1.01M | Buy |
1,513
+61
| +4% | +$40.7K | 0.27% | 56 |
|
|
2021
Q3 | $830K | Buy |
1,452
+14
| +1% | +$8K | 0.24% | 65 |
|
|
2021
Q2 | $777K | Sell |
1,438
-9
| -0.6% | -$4.86K | 0.22% | 69 |
|
|
2021
Q1 | $660K | Sell |
1,447
-17
| -1% | -$7.75K | 0.22% | 73 |
|
|
2020
Q4 | $682K | Buy |
1,464
+275
| +23% | +$128K | 0.23% | 70 |
|
|
2020
Q3 | $525K | Buy |
1,189
+136
| +13% | +$60.1K | 0.22% | 68 |
|
|
2020
Q2 | $382K | Buy |
1,053
+181
| +21% | +$65.7K | 0.17% | 78 |
|
|
2020
Q1 | $247K | Buy |
872
+52
| +6% | +$14.7K | 0.14% | 94 |
|
|
2019
Q4 | $266K | Buy |
+820
| New | +$266K | 0.12% | 104 |
|